Ceric Ammonium Nitrate (CAN) Promoted Efficient Synthesis of 1,5-Benzodiazepine Derivatives

Ravi Varala; Ramu Enugala; Sreelatha Nuvula; Srinivas R. Adapa

doi:10.1055/s-2006-939066

LETTER

Ceric Ammonium Nitrate (CAN) Promoted Efficient Synthesis of 1,5-Benzodiazepine Derivatives [1]

Ravi Varala, Ramu Enugala, Sreelatha Nuvula, Srinivas R. Adapa*
Indian Institute of Chemical Technology, Hyderabad - 500 007, India
Fax: +91(40)27160921; e-Mail: rvarala_iict@yahoo.co.in;

Abstract

Alle Artikel dieser Rubrik

Abstract

Ceric ammonium nitrate was found to be an efficient reagent for the preparation of 1,5-benzodiazepine derivatives of a wide range of substituted o-phenylenediamines and electronically divergent ketones in moderate to excellent isolated yields (60-98%) under mild conditions using methanol as solvent at ambient temperature.

Key words

1,5-benzodiazepines - ceric ammonium nitrate - o-phenylenediamines

Volltext

Referenzen

References and Notes

IICT communication no: 050809.

<A NAME="RD01706ST-2A">2a</A> Werner W. Baumgart J. Burckhardt G. Fleck WF. Geller K. Gutsche W. Hanschmann H. Messerschmidt A. Roemer W. Biophys. Chem. 1990, 35: 271

<A NAME="RD01706ST-2B">2b</A> Herpin TF. Van Kirk KG. Salvino JM. Yu ST. Labaudinière RF. J. Comb. Chem. 2000, 5: 513

<A NAME="RD01706ST-2C">2c</A> Claremon DA, Liverton N, Selnick HG, and Smith GR. inventors; PCT Int. Appl. WO 9640653.

<A NAME="RD01706ST-3A">3a</A> Atwal KS. Bergey JL. Hedberg A. Moreland S. J. Med. Chem. 1987, 30: 635

<A NAME="RD01706ST-3B">3b</A> Merluzzi V. Hargrave KD. Labadia M. Grozinger K. Skoog M. Wu JC. Shih C.-K. Eckner K. Hattox S. Adams J. Rosenthal AS. Faanes R. Eckner RJ. Koup RA. Sullivan JL. Science 1990, 250: 1411

<A NAME="RD01706ST-3C">3c</A> Di Braccio M. Grossi G. Roma G. Vargiu L. Mura M. Marongiu ME. Eur. J. Med. Chem. 2001, 36: 935

<A NAME="RD01706ST-3D">3d</A> Tranquillini ME. Cassara PG. Corsi M. Curotto G. Donati D. Finizia G. Pentassuglia G. Polinelli S. Tarzia G. Ursini A. Van Amsterdam FTM. Arch. Pharm. 1997, 330: 353

<A NAME="RD01706ST-4A">4a</A> Schutz H. Benzodiazepines Springer; Heidelberg: 1982.

<A NAME="RD01706ST-4B">4b</A> Landquist JK. In Comprehensive Heterocyclic Chemistry Vol. 1: Katritzky AR. Rees CW. Pergamon; Oxford: 1984. p.166-170

<A NAME="RD01706ST-4C">4c</A> Randall LO. Kappel B. Benzodiazepines Garattini S. Mussini E. Randall LO. Raven Press; New York: 1973. p.27

<A NAME="RD01706ST-5">5</A> Haris RC, and Straley JM. inventors; US Patent 1537757. ; Chem. Abstr. , 73, 100054w

<A NAME="RD01706ST-6A">6a</A> Essaber M. Baouid A. Hasnaoui A. Benharref A. Lavergne J.-P. Synth. Commun. 1998, 28: 4097

<A NAME="RD01706ST-6B">6b</A> El-Sayed AMEl. Abdel-Ghany H. El-Saghier AMM. Synth. Commun. 1999, 29: 3561

<A NAME="RD01706ST-6C">6c</A> Xu JX. Wu HT. Jin S. Chin. J. Chem. 1999, 17: 84

<A NAME="RD01706ST-6D">6d</A> Zhang XY. Xu JX. Jin S. Chin. J. Chem. 1999, 17: 404

<A NAME="RD01706ST-6E">6e</A> Reddy KVV. Rao PS. Ashok D. Synth. Commun. 2000, 30: 1825

<A NAME="RD01706ST-7A">7a</A> Herbert JAL. Suschitzky H. J. Chem. Soc., Perkin Trans. 1 1974, 2657

<A NAME="RD01706ST-7B">7b</A> Morales HR. Ulbarela BA. Contreras R. Heterocycles 1986, 24: 135

<A NAME="RD01706ST-7C">7c</A> Jung DI. Choi TW. Kim YY. Kim IS. Park YM. Lee YG. Jung DH. Synth. Commun. 1999, 29: 1941

<A NAME="RD01706ST-7D">7d</A> Balakrishna MS. Kaboudin B. Tetrahedron Lett. 2001, 42: 1127

<A NAME="RD01706ST-7E">7e</A> Curini M. Epifano F. Marcotullio MC. Rosati O. Tetrahedron Lett. 2001, 42: 3193

<A NAME="RD01706ST-7F">7f</A> Kaboudin B. Navaee K. Heterocycles 2001, 55: 1443

<A NAME="RD01706ST-7G">7g</A> Pozarentzi M. Stephanatou JS. Tsoleridis CA. Tetrahedron Lett. 2002, 43: 1755

<A NAME="RD01706ST-7H">7h</A> Yadav JS. Reddy BVS. Eshwaraiah B. Anuradha K. Green Chem. 2002, 4: 592

<A NAME="RD01706ST-7I">7i</A> Sabitha G. Reddy GSKK. Reddy KB. Reddy NM. Yadav JS. Adv. Synth. Catal. 2004, 346: 921

<A NAME="RD01706ST-7J">7j</A> Yadav JS. Reddy BVS. Kumar SP. Nagaiah K. Synthesis 2005, 480

<A NAME="RD01706ST-7K">7k</A> Jarikote DV. Siddiqui SA. Rajagopal R. Daniel T. Lahoti RJ. Srinivasan KV. Tetrahedron Lett. 2003, 44: 1835

<A NAME="RD01706ST-7L">7l</A> De SK. Gibbs RA. Tetrahedron Lett. 2005, 46: 1811

<A NAME="RD01706ST-8A">8a</A> Varala R. Ramu E. Alam MM. Adapa SR. Synlett 2004, 1747

<A NAME="RD01706ST-8B">8b</A> Varala R. Ramu E. Alam MM. Adapa SR. Chem. Lett. 2004, 33: 1614

<A NAME="RD01706ST-8C">8c</A> Varala R. Ramu E. Adapa SR. Bull. Chem. Soc. Jpn. 2006, 79: 140

<A NAME="RD01706ST-8D">8d</A> Varala R. Alam MM. Adapa SR. Synlett 2003, 720

<A NAME="RD01706ST-8E">8e</A> Alam MM. Varala R. Adapa SR. Tetrahedron Lett. 2003, 5115

<A NAME="RD01706ST-8F">8f</A> Varala R. Alam MM. Adapa SR. Synlett 2003, 67

<A NAME="RD01706ST-8G">8g</A> Varala R. Ramu E. Adapa SR. Tetrahedron Lett. 2006, 47: 877

<A NAME="RD01706ST-8H">8h</A> Alam MM. Varala R. Ramu E. Adapa SR. Lett. Org. Chem. 2006, 3: 187

For recent reports, see:

<A NAME="RD01706ST-9A">9a</A> Nair V. Balagopal L. Rajan R. Mathew J. Acc. Chem. Res. 2004, 37: 21

<A NAME="RD01706ST-9B">9b</A> Kuttan A. Nowshudin S. Rao MNA. Tetrahedron Lett. 2004, 45: 2663

<A NAME="RD01706ST-9C">9c</A> Comin MJ. Elhalem E. Rodriguez JB. Tetrahedron 2004, 60: 11851

<A NAME="RD01706ST-9D">9d</A> Nair V. Suja TD. Mohanan K. Tetrahedron Lett. 2005, 46: 3217

<A NAME="RD01706ST-9E">9e</A> Fujioka H. Ohba Y. Hirose H. Murai K. Kita Y. Org. Lett. 2005, 7: 3303

Representative Procedure.
A mixture of o-phenylenediamine (1.0 mmol), ketone (2.2 mmol) and CAN (0.055 g, 10 mol%) in MeOH (2 mL) was stirred at r.t. for the time specified in Table [1] . After the reaction was over, the reaction mixture was diluted with H₂O and extracted with Et₂O (3 ¥ 10 mL). The combined organic layers were dried over Na₂SO₄, concentrated in vacuo and purified by column chromatography on silica gel with EtOAc and n-hexane (2:8) as eluent to afford the corresponding pure 1,5-benzodiazapine. Previously reported materials were characterized by comparison of their NMR and mass spectra with those of authentic samples. All novel compounds gave satisfactory spectroscopic data in accordance to their proposed structures.
Spectral Data for Selected Compounds:
Compound 2: pale yellow crystalline solid, mp 98-99 °C. IR (KBr): 3318, 1630, 1598 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.72 (s, 3 H), 2.26 (s, 3 H), 2.32 (s, 3 H), 2.98 (d, J = 13.38 Hz, 1 H), 3.05 (d, J = 13.38 Hz, 1 H), 3.43 (br s, NH), 6.76 (m, 1 H), 7.01 (m, 6 H), 7.23 (m, 1 H), 7.49 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 20.75, 21.16, 29.85, 42.97, 73.06, 121.28, 121.38, 125.18, 126.03, 127.15, 128.50, 128.67, 128.92, 129.22, 136.45, 137.0, 138.18, 139.76, 140.32, 144.98, 166.82. MS (EI): m/z = 340 [M⁺]. [7i]
Compound 3: yellowish solid, mp 114-116 °C. IR (neat): 3325, 1135, 1640, 1594 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.71 (s, 3 H), 2.85 (d, J = 12.84 Hz, 1 H), 2.98 (d, J = 13.60 Hz, 1 H), 3.73 (s, 3 H), 3.77 (s, 3 H), 6.65-6.78 (m, 4 H), 6.95-7.02 (m, 2 H), 7.18-7.25 (m, 2 H), 7.42-7.55 (m, 4 H). MS (EI): m/z = 372 [M⁺].
Compound 4: yellow crystalline solid, mp 219-220 °C. IR (KBr): 3339, 1636, 1599 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.65 (s, 3 H), 2.77 (d, J = 12.63 Hz, 1 H), 2.89 (d, J = 7.43 Hz, 1 H), 4.18 (br s, NH), 6.57-6.64 (m, 4 H), 6.81-7.00 (m, 1 H), 7.10-7.18 (m, 1 H), 7.28-7.55 (m, 4 H).
MS (EI): m/z = 344 [M⁺].
Compound 5: red crystalline solid, mp 156-158 °C. IR (KBr): 3325, 1642, 1597 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.83 (s, 3 H), 2.96 (d, J = 13.38 Hz, 1 H ), 3.27 (d, J = 13.38 Hz, 1 H), 3.52 (br s, NH), 6.98 (m, 1 H), 7.00 (m, 6 H), 7.22 (m, 1 H), 7.47 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 30.02, 42.92, 73.37, 121.29, 122.16, 123.53, 123.38, 126.78, 127.57, 127.75, 129.58, 137.23, 138.80, 144.65, 146.95, 148.40, 154.05, 163.82. MS (EI): m/z =
402 [M⁺].
Compound 6 (X = F): pale-yellow crystalline solid, mp 104-105 °C. IR (KBr): 3271, 1651, 1603, 1231 cm^-1.
¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.87 (d, J = 13.60 Hz, 1 H), 3.04 (d, J = 12.84 Hz, 1 H), 3.30 (br s, NH), 6.75-6.79 (m, 1 H), 6.82-6.92 (m, 4 H), 7.00-7.05 (m, 2 H), 7.19-7.25 (m, 1 H), 7.48-7.62 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 29.72, 42.94, 73.38, 114.70, 114.79, 114.97, 115.06, 126.22, 127.0, 128.50, 129.20, 135.46, 137.44, 140.36, 143.2, 160.23, 162.22, 165.26, 165.53, 163.50. MS (EI): m/z = 348 [M⁺].
Compound 9: pale-yellow crystalline solid; mp 102-103 °C. IR (KBr): 3325, 1636, 1594 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.72 (s, 3 H), 2.26-2.36 (s, 6 H), 2.45 (s, 3 H), 2.58 (s, 3 H), 2.91 (d, J = 12.84 Hz, 1 H), 3.03 (d, J = 13.60 Hz, 1 H), 3.29 (br s, NH), 6.56 (s, 1 H), 7.02-7.07 (m, 1 H), 7.24-7.28 (m, 4 H), 7.47-7.53 (m, 2 H), 7.83-7.87 (d, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 19.12, 21.10, 29.88, 43.06, 72.88, 122.34, 125.24, 127.05, 128.44, 128.76, 128.94, 129.58, 129.60, 134.58, 136.56, 137.26, 137.96, 139.68, 166.76. MS (EI): m/z = 368 [M⁺].
Compound 10: yellow crystalline solid, mp 158-160 °C. IR (KBr): 3304, 1638, 1603, 761 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.93 (d, J = 13.60 Hz, 1 H), 3.12 (d, J = 12.84 Hz, 1 H), 3.49 (br s, NH), 6.88 (s, 1 H), 7.13-7.30 (m, 5 H), 7.36 (s, 1 H), 7.50-7.53 (m, 5 H). ¹³C NMR (75 MHz, CDCl₃): δ = 29.97, 43.23, 72.97, 121.90, 124.14, 125.33, 127.30, 128.35, 128.76, 130.13, 137.84, 139.26, 146.83, 168.81. MS (EI): m/z = 381 [M⁺].
Compound 11: pale-yellow solid, mp 179-180 °C. IR (KBr): 3434, 1636, 1597, 817 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.34 (s, 3 H), 2.37 (s, 3 H), 2.95 (d, J = 13.60 Hz, 1 H), 3.09 (d, J = 13.60 Hz, 1 H), 3.50 (br s, NH), 6.88 (s, 1 H), 7.05-7.09 (t, 3 H), 7.28 (s, 1 H), 7.38-7.44 (t, 3 H), 7.50-7.53 (d, 2 H). MS (EI): m/z = 409 [M⁺].
Compound 12: pale-yellow crystalline solid, mp 199-200 °C. IR (KBr): 3325, 1630, 1594 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.77 (s, 3 H), 2.88 (d, J = 13.60 Hz, 1 H), 3.11 (d, J = 13.60 Hz, 1 H), 3.48 (br s, NH), 6.92 (s, 1 H), 7.21-7.25 (m, 4 H), 7.38 (s, 1 H), 7.45-7.51 (m, 4 H). MS (FAB): m/z = 451 [M⁺ + 1].
Compound 13: reddish crystalline solid, mp 218-220 °C. IR (KBr): 3387, 1640, 1585 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.74 (s, 3 H), 2.69 (d, J = 9.82 Hz, 1 H), 2.82 (d, J = 11.33 Hz, 1 H), 2.93 (br s, NH), 6.92 (s, 1 H), 7.21-7.25 (m, 4 H), 7.38 (s, 1 H), 7.45-7.51 (m, 4 H). MS (FAB): m/z = 472 [M⁺ + 1].
Compound 15 (R = R¹ = Cl): reddish crystalline solid, mp 92-94 °C. IR (KBr): 3325, 1636, 1590 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.35 (s, 6 H), 2.26 (s, 2 H), 2.34 (s, 1 H), 6.78 (s, 1 H), 7.18 (s, 1 H). MS (EI): m/z = 257 [M⁺].